The trial showed that 63% of patients achieved a complete response (CR) at any time after receiving detalimogene coraplasmid.

Detalimogene voraplasmid (detalimogene; formerly EG-70) demonstrated promising responses in patients with high-risk Bacillus ...

-- 63% complete response (CR) rate at any time (n=62); -- 56% CR rate at 3 months (n=62); -- 62% CR rate at 6 months (n=37), with 4 patients having successfully converted to CR post reinduction; and - ...

Understanding changes, seeking support, and staying connected can help caregivers adapt to the challenges of secondary progressive MS.

With rates of advanced prostate cancer on the rise, local medical experts offer advice on screenings, risks, and new ...

People receiving unregulated Botox treatment are placing themselves at a “serious risk of harm”, according to a medical ...

A man who hasn’t been able to feel anything in his genitals since he was a teenager says he is ‘sleepwalking through life’ ...

A Los Angeles area hospital is asking for the public’s help to identify a woman who has been receiving care for the past two ...

MARK Beattie was sitting at his computer when, at just 14, he suddenly lost all feeling in his penis. “I can remember it was ...

The great unknown, the final frontier – death. It’s a topic shrouded in both fear and morbid curiosity, a universal ...

Mark Beattie, 32, from Newtownabbey in Co Antrim, said he was sitting at his computer one day in his teenage years when he ...